Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Hutchinson KE"'
Autor:
Lee KM, Giltnane JM, Balko JM, Schwarz LJ, Guerrero-Zotano AL, Hutchinson KE, Nixon MJ, Estrada MV, Sánchez V, Sanders ME, Lee T, Gómez H, Lluch A, Pérez-Fidalgo JA, Wolf MM, Andrejeva G, Rathmell JC, Fesik SW, Arteaga CL
Publikováno v:
Cell Metabolism
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::088b7ca1343d71600630ef70818a8ca3
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=2190
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=2190
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Monica V. Estrada, Melinda E. Sanders, Christian D. Young, Monica Red-Brewer, Michael Kragh, Katherine E. Hutchinson, Carlos L. Arteaga, Teresa C. Dugger, Mikkel Wandahl Pedersen, Brent N. Rexer, Paula Gonzalez Ericsson, Angel Guerrero-Zotano, Luis J. Schwarz, Johan Lantto, Ivan D Horak, Luigi Formisano
BACKGROUND: Plasticity of the ERBB receptor network has been suggested to cause acquired resistance to anti–human epidermal growth factor receptor 2 (HER2) therapies. Thus, we studied whether a novel approach using an ERBB1-3-neutralizing antibody
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35bd3794dbce2dda63c3562556360f45
http://hdl.handle.net/11588/698505
http://hdl.handle.net/11588/698505
Autor:
Chen JW; Oncology Biomarker Development, Genentech, Inc., South San Francisco, CA, USA., Jacot W; Institut du Cancer de Montpellier (ICM) Val d'Aurelle, Montpellier University, INSERM U1194, France., Cortés J; International Breast Cancer Center (IBCC), Pangaea Oncology, Quironsalud Group, Madrid, Spain.; International Breast Cancer Center (IBCC), Pangaea Oncology, Quironsalud Group, Barcelona, Spain.; Faculty of Biomedical and Health Sciences, Department of Medicine, Universidad Europea de Madrid, Madrid, Spain., Krop IE; Yale Cancer Center, New Haven, CT, USA., Dent S; Duke Cancer Institute, Duke University, Durham, NC, USA., Harbeck N; Breast Center, Department Gynecology and Obstetrics and Comprehensive Cancer Center (CCC) Munich, Ludwig-Maximilians-University (LMU) Hospital, Munich, Germany., De Laurentiis M; Istituto Nazionale Tumori IRCCS 'Fondazione Pascale', Napoli, Italy., Diéras V; Department of Medical Oncology, Centre Eugène Marquis, Rennes, France., Im YH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Stout TJ; Product Development Oncology, Genentech, Inc., South San Francisco, CA, USA., Schimmoller F; Product Development Oncology, Genentech, Inc., South San Francisco, CA, USA., Savage HM; Oncology Biomarker Development, Genentech, Inc., South San Francisco, CA, USA., Hutchinson KE; Oncology Biomarker Development, Genentech, Inc., South San Francisco, CA, USA., Wilson TR; Oncology Biomarker Development, Genentech, Inc., South San Francisco, CA, USA.
Publikováno v:
Molecular oncology [Mol Oncol] 2023 Oct; Vol. 17 (10), pp. 2000-2016. Date of Electronic Publication: 2023 Mar 25.
Autor:
Hutchinson KE; Oncology Biomarker Development, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA., Chen JW; Oncology Biomarker Development, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA., Savage HM; Oncology Biomarker Development, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA., Stout TJ; Product Development Oncology, Genentech, Inc., South San Francisco, CA, USA., Schimmoller F; Product Development Oncology, Genentech, Inc., South San Francisco, CA, USA., Cortés J; International Breast Cancer Center (IBCC), Pangaea Oncology, Quironsalud Group, Madrid & Barcelona, Spain.; Department of Medicine, Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Madrid, Spain., Dent S; Duke Cancer Institute, Duke University, Durham, NC, USA., Harbeck N; Breast Center, Department Gynecology and Obstetrics and Comprehensive Cancer Center (CCC) Munich, Ludwig-Maximilians-University (LMU) Hospital, Munich, Germany., Jacot W; Institut du Cancer de Montpellier (ICM) Val d'Aurelle, Montpellier University, INSERM U1194, Montpellier, France., Krop I; Yale Cancer Center, New Haven, CT, USA., Trabucco SE; Foundation Medicine, Inc, Cambridge, MA, USA., Sivakumar S; Foundation Medicine, Inc, Cambridge, MA, USA., Sokol ES; Foundation Medicine, Inc, Cambridge, MA, USA., Wilson TR; Oncology Biomarker Development, Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA. wilson.timothy@gene.com.
Publikováno v:
Genome medicine [Genome Med] 2023 Apr 26; Vol. 15 (1), pp. 28. Date of Electronic Publication: 2023 Apr 26.
Autor:
Nabbi A; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Danesh A; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Espin-Garcia O; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada.; Dalla Lana School of Public Health and Department of Statistical Sciences, University of Toronto, Toronto, Ontario, Canada., Pedersen S; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Wellum J; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Fu LH; Clinical Biomarker Operations, Product Development Oncology, Genentech, South San Francisco, CA, USA., Paulson JN; Department of Biostatistics, Product Development, Genentech, South San Francisco, CA, USA., Geoerger B; Gustave Roussy Cancer Centre, Department of Pediatric and Adolescent Oncology, INSERM U1015, Université Paris-Saclay, Villejuif, France., Marshall LV; The Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, London, UK., Trippett T; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Rossato G; Product Development Clinical Oncology, F. Hoffmann-La Roche, Basel, Switzerland., Pugh TJ; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. trevor.pugh@utoronto.ca.; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada. trevor.pugh@utoronto.ca.; Ontario Institute for Cancer Research, Toronto, Ontario, Canada. trevor.pugh@utoronto.ca., Hutchinson KE; Oncology Biomarker Development, Genentech, South San Francisco, CA, USA. hutchinson.katherine@gene.com.
Publikováno v:
Nature cancer [Nat Cancer] 2023 Apr; Vol. 4 (4), pp. 502-515. Date of Electronic Publication: 2023 Apr 10.
Autor:
Sivakumar S; Foundation Medicine, Cambridge, Massachusetts., Jin DX; Foundation Medicine, Cambridge, Massachusetts., Rathod R; Department of Medicine, Division of Hematology/Oncology, Columbia University Irving Medical Center, New York, New York., Ross J; Foundation Medicine, Cambridge, Massachusetts.; Departments of Pathology and Urology, Upstate Medical University, Syracuse, New York., Cantley LC; Dana-Farber Cancer Institute, Boston, Massachusetts., Scaltriti M; AstraZeneca, Gaithersburg, Maryland., Chen JW; Oncology Biomarker Development, Genentech, South San Francisco, California., Hutchinson KE; Oncology Biomarker Development, Genentech, South San Francisco, California., Wilson TR; Oncology Biomarker Development, Genentech, South San Francisco, California., Sokol ES; Foundation Medicine, Cambridge, Massachusetts., Vasan N; Department of Medicine, Division of Hematology/Oncology, Columbia University Irving Medical Center, New York, New York.; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Mar 14; Vol. 29 (6), pp. 1125-1136.
Autor:
Chen JW; Oncology Biomarker Development, Genentech, Inc, South San Francisco, CA., Murugesan K; Cancer Genomics Research, Foundation Medicine, Inc, Cambridge, MA., Newberg JY; Cancer Genomics Research, Foundation Medicine, Inc, Cambridge, MA., Sokol ES; Cancer Genomics Research, Foundation Medicine, Inc, Cambridge, MA., Savage HM; Oncology Biomarker Development, Genentech, Inc, South San Francisco, CA., Stout TJ; Product Development Oncology, Genentech, Inc, South San Francisco, CA., Maund SL; Oncology Biomarker Development, Genentech, Inc, South San Francisco, CA., Hutchinson KE; Oncology Biomarker Development, Genentech, Inc, South San Francisco, CA.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2022 Nov; Vol. 6, pp. e2200341.
Autor:
Desai AV; Department of Pediatrics, Section of Hematology/Oncology/Stem Cell Transplantation, University of Chicago Medical Center, Chicago, Illinois, USA., Robinson GW; Division of Neuro-Oncology, Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Gauvain K; Pediatric Neuro-Oncology, Washington University School of Medicine, St. Louis, Missouri, USA., Basu EM; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Macy ME; Pediatric Hematology-Oncology, Children's Hospital Colorado, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Maese L; Department of Pediatrics, Division of Hematology/Oncology, University of Utah/Huntsman Cancer Institute, Salt Lake City, Utah, USA., Whipple NS; Pediatric Hematology-Oncology, University of Utah, Salt Lake City, Utah, USA., Sabnis AJ; Division of Pediatric Oncology, Department of Pediatrics, University of California, San Francisco, California, USA., Foster JH; Department of Pediatrics, Hematology-Oncology, Texas Children's Hospital, Houston, Texas, USA., Shusterman S; Pediatric Hematology and Oncology, Dana Farber Cancer Institute/Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA., Yoon J; Department of Pediatrics, University of California San Diego, San Diego, California, USA., Weiss BD; Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA., Abdelbaki MS; Division of Hematology & Oncology, Nationwide Children's Hospital, Columbus, Ohio, USA., Armstrong AE; Division of Pediatric Hematology/Oncology, Washington University School of Medicine, St. Louis, Missouri, USA., Cash T; Pediatric Hematology/Oncology, Aflac Cancer & Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia, USA., Pratilas CA; Department of Oncology, Division of Pediatric Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Corradini N; Department of Pediatric Hematology and Oncology, Institute of Pediatric Hematology and Oncology (IHOPe), Léon Bérard Cancer Centre, Lyon, France., Marshall LV; Children and Young People's Unit, The Royal Marsden Hospital and The Institute of Cancer Research, London, UK., Farid-Kapadia M; Biometrics Department, F. Hoffmann-La Roche Ltd., Mississauga, Ontario, Canada., Chohan S; PDD Data & Statistical Sciences, F. Hoffmann-La Roche Ltd., Mississauga, Ontario, Canada., Devlin C; Pharma Development Oncology and Hematology, Roche Products Ltd., Welwyn Garden City, UK., Meneses-Lorente G; Pharma Research and Early Development, Roche Products Ltd., Welwyn Garden City, UK., Cardenas A; Clinical Safety, Genentech, Inc., South San Francisco, California, USA., Hutchinson KE; Oncology Biomarker Development, Genentech, Inc., South San Francisco, California, USA., Bergthold G; Product Development Oncology, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Caron H; Product Development Oncology, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Chow Maneval E; Clinical Development, Ignyta, Inc., San Diego, California, USA., Gajjar A; Division of Neuro-Oncology, Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Fox E; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Publikováno v:
Neuro-oncology [Neuro Oncol] 2022 Oct 03; Vol. 24 (10), pp. 1776-1789.